STUELPNAGEL JOHN R 4
4 · 10x Genomics, Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4
STUELPNAGEL JOHN R
Director
Transactions
- Award
Class A Common Stock
2022-06-15+2,120→ 343,736 total - Award
Stock Option (right to buy)
2022-06-15+5,300→ 5,300 totalExercise: $39.62Exp: 2032-06-15→ Class A Common Stock (5,300 underlying)
Footnotes (2)
- [F1]These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock. One-fourth of the RSUs, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, shall vest on August 21, 2022 and on each three-month anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
- [F2]This option, granted pursuant to the Issuer's 2019 Omnibus Incentive Plan, vests as to one-twelfth of the shares on July 15, 2022 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.